Here we have demonstrated that AURKB inhibition in RB+p53 defective cancer cells, irrespective of their different genetic backgrounds results in the formation of hyper-polyploid cells that do not have long-term proliferative capacity either in vitro or in vivo. Here, TP53 is linked to cancer.